Also, given advancements in CF care and widespread use of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy, pwCF are increasingly unable to routinely expectorate sputum [12] and are presenting less often to clinic or with pulmonary exacerbations [13]. Here, CFTR is linked to cystic fibrosis.